Vitiligo develops when the immune system attacks and destroys melanocytes, the cells that produce skin pigment. It affects roughly 0.3% to 0.5% of the global population, and no single cause explains every case. Instead, a combination of genetic susceptibility, immune system malfunction, and environmental triggers determines who develops it and when.
The Immune System Turns on Pigment Cells
At its core, vitiligo is an autoimmune condition. The immune system, which normally fights infections, mistakenly identifies melanocytes as threats and destroys them. Once enough melanocytes are gone from a patch of skin, that area loses its color and appears white or light pink. This process can happen slowly over years or progress rapidly over months, depending on the type of vitiligo involved.
Exactly what triggers the immune system to make this mistake varies from person to person, but the result is the same: pigment-producing cells die, and the skin can no longer maintain its natural color in the affected areas.
Genetics Load the Gun
Vitiligo runs in families, though inheriting the genes doesn’t guarantee you’ll develop it. Researchers have identified multiple susceptibility genes on different chromosomes that increase risk. Many of these genes are involved in immune regulation, which makes sense given the autoimmune nature of the disease. One well-studied gene, NLRP1, plays a role in the body’s inflammatory response and has been linked not just to vitiligo but to a broader tendency toward autoimmune conditions.
These genes don’t work in isolation. Studies have found significant interaction effects between susceptibility signals on multiple chromosomes, meaning that having risk variants at several genetic locations simultaneously raises your chances more than any single gene would alone. This is why vitiligo patients and their relatives often have higher rates of other autoimmune diseases, including thyroid disorders and alopecia areata (autoimmune hair loss).
If a close family member has vitiligo, your risk is elevated but still relatively small. Most people with a genetic predisposition never develop the condition. Something in the environment or the body has to flip the switch.
Stress and the Nervous System
One of the more compelling theories about vitiligo triggers involves the nervous system. People with vitiligo show significantly elevated levels of stress-related chemicals called catecholamines, including adrenaline and dopamine, in their blood. These chemicals spike further during active disease compared to stable phases. The connection to emotional stress is more than anecdotal: the same raw material (the amino acid tyrosine) is used to make both melanin and these stress chemicals. When the body diverts tyrosine toward stress chemical production, less is available for pigment.
Dopamine is particularly damaging. It generates oxidative stress and can directly trigger cell death in melanocytes. Elevated catecholamines also constrict blood vessels, reducing oxygen supply to the skin, and their breakdown products create toxic molecules that further harm pigment cells. People with vitiligo also show increased levels of serotonin and melatonin. Higher melatonin activity at nerve endings in the skin lightens pigment cells and decreases new melanin formation.
This helps explain why many people notice their vitiligo appearing or worsening during periods of significant emotional or physical stress.
Chemical Exposure
Certain industrial and consumer chemicals can trigger vitiligo in susceptible people or worsen existing cases. The culprits are typically phenol-based compounds found in products like hair dyes, rubber, adhesives, and some skin-lightening creams. A notable outbreak in Japan was traced to rhododenol, an ingredient in a popular skin-brightening cosmetic.
These chemicals are structurally similar to the building blocks of melanin, which may cause the immune system to confuse melanocytes with the foreign chemical and attack them. There is evidence that when people identify and avoid the offending chemical, their response to treatment improves dramatically, and some eliminate their vitiligo entirely. The challenge is that beyond a handful of known triggers (monobenzone, 4-TBP, 4-TBC, and rhododenol), it’s difficult to know which chemicals pose a risk before an outbreak occurs.
Skin Injury and the Koebner Phenomenon
Physical trauma to the skin can trigger new vitiligo patches in a process called the Koebner phenomenon. Any injury that penetrates both the outer and middle layers of skin, including cuts, burns, scrapes, and even severe sunburns, can cause depigmented patches to appear at the injury site within 10 to 20 days. The new patches look identical to existing vitiligo and typically form in a straight line following the path of the wound.
This is why some people first notice vitiligo after surgery, a tattoo, or a bad sunburn. The trauma seems to expose melanocytes to the immune system in a way that initiates or spreads the autoimmune attack. Not everyone with vitiligo experiences the Koebner phenomenon, and researchers still don’t fully understand why some people are susceptible to it while others aren’t.
Two Types With Different Patterns
Vitiligo doesn’t behave the same way in everyone, and the two main types suggest somewhat different underlying mechanisms.
Non-segmental vitiligo is the more common form. Patches appear symmetrically on both sides of the body, such as on both hands or both knees, and the condition tends to spread slowly with new patches developing off and on throughout a person’s lifetime. Color loss can occur anywhere on the body, ranging from a few localized spots to widespread coverage. In rare cases, called universal vitiligo, most of the skin’s color is eventually lost.
Segmental vitiligo behaves quite differently. It affects only one side or one segment of the body, spreads rapidly for about 6 to 12 months, and then stabilizes. Once it stops, most people don’t develop new patches. Hair in the affected area, whether on the scalp, eyebrows, or eyelashes, may turn white. Most people develop segmental vitiligo before age 30. The one-sided distribution and its association with nerve pathways support the neural theory, suggesting nerve-related chemical signals play a larger role in this type.
Linked Autoimmune Conditions
Vitiligo frequently co-occurs with other autoimmune diseases, reinforcing the idea that underlying immune dysfunction is central to the condition. Autoimmune thyroid disease is the most common and well-documented association. Dermatologists also see frequent overlap with eczema and alopecia areata. If you develop vitiligo, your doctor will likely check thyroid function and watch for signs of other autoimmune conditions, since sharing the same genetic susceptibility factors means these diseases tend to cluster together.
How Vitiligo Is Confirmed
Diagnosis is primarily visual. A dermatologist examines the skin and reviews your medical history and symptoms. To confirm the diagnosis, they may use a Wood’s lamp, which emits ultraviolet light that makes areas without melanocytes glow bright white, even in patches that might be subtle under normal lighting. A skin biopsy, which would show a complete absence of melanocytes, is rarely needed. Blood tests aren’t required for diagnosis but are often ordered to screen for related autoimmune conditions like thyroid disease.